364 related articles for article (PubMed ID: 31047662)
1. An integrated strategy for ascertaining quality marker of Schisandra chinensis (Turcz.) Baill based on correlation analysis between depression-related monoaminergic metabolites and chemical components profiling.
Zhang Y; Lv X; Liu R; Zhang M; Liu H; Gao H; Zhang Q; Xu H; Li Q; Bi K
J Chromatogr A; 2019 Aug; 1598():122-131. PubMed ID: 31047662
[TBL] [Abstract][Full Text] [Related]
2. A multidimensional strategy for uncovering comprehensive quality markers of Schisandra chinensis (Turcz.) Baill based on pharmacodynamics and chemical properties.
Zhang Y; Li S; Yang P; Zhang Q; Xu H; Bi K; Li Q
Phytomedicine; 2022 Nov; 106():154273. PubMed ID: 36044818
[TBL] [Abstract][Full Text] [Related]
3. Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Wei B; Li Q; Su D; Fan R; Zhao L; Geng L; He B; Chen X; Jia Y; Bi K
J Pharm Biomed Anal; 2013 Apr; 77():120-7. PubMed ID: 23416367
[TBL] [Abstract][Full Text] [Related]
4. UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples: towards an in-depth study for its sedative-hypnotic activity.
Wei B; Li Q; Fan R; Su D; Ou X; Chen K; Chen X; Jia Y; Bi K
J Mass Spectrom; 2013 Apr; 48(4):448-58. PubMed ID: 23584938
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive chemical analysis of Schisandra chinensis by HPLC-DAD-MS combined with chemometrics.
Liu H; Lai H; Jia X; Liu J; Zhang Z; Qi Y; Zhang J; Song J; Wu C; Zhang B; Xiao P
Phytomedicine; 2013 Sep; 20(12):1135-43. PubMed ID: 23880331
[TBL] [Abstract][Full Text] [Related]
6. [Lignans from different processed products of Schisandra chinensis fruits].
Huang X; Song FR; Liu ZQ; Liu SY
Yao Xue Xue Bao; 2008 Jun; 43(6):630-3. PubMed ID: 18822967
[TBL] [Abstract][Full Text] [Related]
7. [Simultaneous quantitative analysis of four lignanoids in Schisandra chinensis by quantitative analysis of multi-components by single marker].
He FC; Li SX; Zhao ZQ; Dong JP; Liu WZ; Su RQ
Yao Xue Xue Bao; 2012 Jul; 47(7):930-3. PubMed ID: 22993860
[TBL] [Abstract][Full Text] [Related]
8. Relaxant effects of Schisandra chinensis and its major lignans on agonists-induced contraction in guinea pig ileum.
Yang JM; Ip PS; Che CT; Yeung JH
Phytomedicine; 2011 Oct; 18(13):1153-60. PubMed ID: 21764275
[TBL] [Abstract][Full Text] [Related]
9. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
[TBL] [Abstract][Full Text] [Related]
10. Non-thermal extraction of effective ingredients from Schisandra chinensis Baill and the antioxidant activity of its extract.
Liu C; Zhang S; Wu H
Nat Prod Res; 2009; 23(15):1390-401. PubMed ID: 19809911
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS.
Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
J Pharm Biomed Anal; 2020 Jan; 177():112874. PubMed ID: 31542420
[TBL] [Abstract][Full Text] [Related]
12. Isolation of three dibenzocyclooctadiene lignans from in vitro cultures of Schisandra chinensis (Turcz.) Baill.--the first report.
Szopa A; Kisiel W; Ekiert H; Szewczyk A
Pharmazie; 2015 May; 70(5):337-9. PubMed ID: 26062304
[TBL] [Abstract][Full Text] [Related]
13. Comparative Phytochemical Analysis of Chinese and Bay Starvine (Schisandra spp.): Potential for Development as a New Dietary Supplement Ingredient.
Lyles JT; Tyler P; Bradbury EJ; Nelson K; Brown CF; Pierce ST; Quave CL
J Diet Suppl; 2017 Nov; 14(6):640-652. PubMed ID: 28384001
[TBL] [Abstract][Full Text] [Related]
14. Metabolic mapping of Schisandra chinensis lignans and their metabolites in rats using a metabolomic approach based on HPLC with quadrupole time-of-flight MS/MS spectrometry.
Wang J; Jiang B; Shan Y; Wang X; Lv X; Mohamed J; Li H; Wang C; Chen J; Sun J
J Sep Sci; 2020 Jan; 43(2):378-388. PubMed ID: 31625256
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between components changes and efficacy of Shengmaisan VII. Chemical dynamic change of schisandrin in Shengmaisan].
Yue L; Zhu DN; Yan YQ; Yu BY
Zhongguo Zhong Yao Za Zhi; 2006 Jun; 31(12):1010-2. PubMed ID: 17048652
[TBL] [Abstract][Full Text] [Related]
16. Systematically Characterize the Anti-Alzheimer's Disease Mechanism of Lignans from
Wei M; Liu Y; Pi Z; Li S; Hu M; He Y; Yue K; Liu T; Liu Z; Song F; Liu Z
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934777
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neuroactive effects of ethanol extract of Schisandra chinensis, Schisandrin, and Schisandrin B and determination of underlying mechanisms by zebrafish behavioral profiling.
Wang JW; Liang FY; Ouyang XS; Li PB; Pei Z; Su WW
Chin J Nat Med; 2018 Dec; 16(12):916-925. PubMed ID: 30595216
[TBL] [Abstract][Full Text] [Related]
18. Characterisation and identification of isomeric dibenzocyclooctadiene lignans from Schisandra Chinensis by high-performance liquid chromatography combined with electrospray ionisation tandem mass spectrometry.
Shi P; He Q; Zhang Y; Qu H; Cheng Y
Phytochem Anal; 2009; 20(3):197-206. PubMed ID: 19259942
[TBL] [Abstract][Full Text] [Related]
19. [Intestinal absorption of the effective components of Schisandra chinensis Baill by rats single-pass perfusion in situ].
Chen XM; Li JS; Li W; Han L; Liu XH; Di LQ; Cai BC
Yao Xue Xue Bao; 2010 May; 45(5):652-8. PubMed ID: 20931771
[TBL] [Abstract][Full Text] [Related]
20. Lignans in Schisandra chinensis in vitro cultures.
Szopa A; Ekiert H
Pharmazie; 2011 Aug; 66(8):633-4. PubMed ID: 21901991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
